Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enara Health vs Queen RX

Enara Health
Graded #226

Lower grade

vs+0.7000000000000028
Queen RX
Graded #214

Higher grade

The verdict

Queen RX takes it — 66/100 to 65.3/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Enara Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +31
45
76
Dose & formulationQueen RX +4
53
57
Clinical oversightEnara Health +23
92
69
Labs & monitoringEnara Health +32
85
53
FulfillmentQueen RX +9
66
75
Contract termsQueen RX +6
55
61
Enara Health · left barQueen RX · right bar

The numbers

MetricEnara HealthQueen RX
WeighScore65.3/10066/100
GradeCC
Scorecard rank#226#214
SemaglutideNot disclosed$100/mo (quarterly plan, compounded)
TirzepatideNot disclosedNot disclosed
Coverage6 states45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Enara Health

Graded #226 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
  • Insurance-based with prior-auth coverage for over 65% of members
  • Board-certified obesity-medicine physicians
  • Comprehensive program: dietitian, coaching, metabolic and genetic testing
  • Established since 2015 with clinical track record

Where it loses points

  • Available in only six states via partner clinics
  • Requires in-network insurance; not a flat cash-pay option
  • Not a pure-telehealth nationwide service
  • Out-of-pocket cost varies by insurance coverage
  • No compounded budget alternative for the uninsured
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard